Table 2. Comparisons of AUC for the discrimination between breast cancer and benign tissue by BPER.
Menopause status | Phase | AUC | 95%CI | P | Cutoffpoint | Sensitivity | Specificity | |
---|---|---|---|---|---|---|---|---|
Cancer vs normal | Premenopausal | Early | 0.665 | 0.555-0.775 | 0.006 | |||
Mid | 0.704 | 0.599-0.808 | 0.001 | 40.3% | 65.96% | 68.09% | ||
Late | 0.687 | 0.580-0.794 | 0.002 | |||||
Postmenopausal | Early | 0.668 | 0.567-0.769 | 0.003 | 10.05% | 87.04% | 40.74% | |
Mid | 0.647 | 0.543-0.751 | 0.008 | |||||
Late | 0.631 | 0.524-0.738 | 0.019 | |||||
Cancer vs benign | Premenopausal | Early | 0.554 | 0.437-0.672 | 0.364 | |||
Mid | 0.622 | 0.509-0.736 | 0.041 | 51.4% | 46.81% | 78.72% | ||
Late | 0.581 | 0.465-0.698 | 0.173 | |||||
Postmenopausal | Early | 0.633 | 0.529-0.738 | 0.017 | 13.3% | 72.22% | 46.3% | |
Mid | 0.565 | 0.456-0.674 | 0.244 | |||||
Late | 0.545 | 0.436-0.654 | 0.421 |
AUC, area under the curve; BPER, background parenchymal enhancement rate; CI, confidence interval